Ftse Mib
38.655,09
0,08%
DAX
22.551,43
0,12%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
85.145,43
0,92%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Corcept Therapeutics Inc (CORT) Corcept Therapeutics Inc (CORT) Notizie

Corcept Therapeutics Inc

CORT
61,00
1,15 (1,92%)
01 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/2/202522:18EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202522:06EDGAR2Form 8-K - Current report
26/2/202522:05BWCorcept Therapeutics Announces Fourth Quarter and Full-Year..
15/2/202503:08EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/2/202502:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202522:05BWCorcept Therapeutics to Announce Fourth Quarter and..
10/2/202517:36EDGAR2Form 144 - Report of proposed sale of securities
05/2/202522:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202519:33EDGAR2Form 144 - Report of proposed sale of securities
03/2/202519:17EDGAR2Form 144 - Report of proposed sale of securities
25/1/202502:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202517:00PRNUSKuehn Law Encourages Investors of Corcept Therapeutics Inc...
15/1/202501:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202516:49EDGAR2Form 144 - Report of proposed sale of securities
07/1/202501:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202501:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202500:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202518:03EDGAR2Form 144 - Report of proposed sale of securities
02/1/202517:58EDGAR2Form 144 - Report of proposed sale of securities
02/1/202517:52EDGAR2Form 144 - Report of proposed sale of securities
31/12/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202423:20EDGAR2Form 8-K - Current report
30/12/202423:15BWCorcept Submits New Drug Application for Relacorilant as a..
16/12/202414:00BWCorcept’s Phase 3 Long-Term Extension Study of Relacorilant..
12/12/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202422:05BWCorcept Announces Positive Results in Treatment Phase of..
11/12/202422:05BWCorcept Announces Results From Phase 2 Study of Dazucorilant..
10/12/202416:00EDGAR2Form 144 - Report of proposed sale of securities
05/12/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202401:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202420:36EDGAR2Form 144 - Report of proposed sale of securities
22/11/202417:41EDGAR2Form 144 - Report of proposed sale of securities
14/11/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202417:55EDGAR2Form 144 - Report of proposed sale of securities
30/10/202421:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202421:09EDGAR2Form 8-K - Current report
30/10/202421:05BWCorcept Therapeutics Announces Third Quarter Financial..
23/10/202423:05BWCorcept Therapeutics to Announce Third Quarter Financial..
23/10/202422:05BWCorcept Therapeutics to Announce Third Quarter Financial..
03/10/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202418:55EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 60,38 Min: 59,12 Max: 61,04
Chiusura: 59,85

La tua Cronologia

NASDAQ
CORT
Corcept Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci